Robert Califf Offers ‘A Few Words In Favor Of The Tortoise’ When Conducting Clinical Trials

The once and likely future FDA commissioner emphasizes value of randomized controlled trials, the fact that not all trials are good for people, and how decentralization and digitization are leaving people behind. Takeda exec questions if industry is being bold enough.